RSV VACCINERESEARCH STUDY
Respiratory Syncytial Virus (RSV) is a leading cause of serious respiratory tract disease in older adults.
RSV is a very common, contagious virus that causes infections of the respiratory tract. Respiratory Syncytial Virus (RSV) is a highly contagious virus that impacts everyone and in mild cases presents like a common cold. However, RSV can also cause more serious respiratory illness, mainly in older adults and in young infants. Like influenza (flu), RSV is seasonal and is common during the winter months in temperate climates. RSV and flu are different viruses. Therefore, you can still get an RSV infection even if you have been vaccinated against the flu.
RSV can lead to serious complications, such as pneumonia in older adults. RSV may also worsen some existing conditions, such as chronic respiratory or heart disease.
There is no approved vaccine yet to prevent RSV infection, but researchers are working hard to develop one, including here in Hartsdale.
Drug Trials America is looking for healthy volunteers aged 60 and older to participate in a research study evaluating if a single dose of an investigational RSV vaccine is safe and can help protect against RSV disease.
Participants receive study-related medication at no cost and will be compensated up to $475 for time and travel.
To see if you are eligible, please complete the form to get in touch with your local study coordinator.